1. Sun, Wei, Zhang, Yongchao, Liu, Bozhi, Li, Wei, Chen, Jinglong. 2021. Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma. In Canadian journal of gastroenterology & hepatology, 2021, 9990305. doi:10.1155/2021/9990305. https://pubmed.ncbi.nlm.nih.gov/34007838/
2. Guo, Huiqin, Zhang, Wei-Xin, Zhang, Qiu-Yan, Miao, Lei, Xia, Huimin. 2023. MUC15 is an independent prognostic factor that promotes metastases of MYCN non-amplified neuroblastoma. In Journal of Cancer, 14, 3496-3507. doi:10.7150/jca.89360. https://pubmed.ncbi.nlm.nih.gov/38021164/
3. Cheng, Meixiong, Liu, Ling. 2020. MUC15 promotes growth and invasion of glioma cells by activating Raf/MEK/ERK pathway. In Clinical and experimental pharmacology & physiology, 47, 1041-1048. doi:10.1111/1440-1681.13277. https://pubmed.ncbi.nlm.nih.gov/32031702/
4. Tang, Lifeng, Zhong, Xuemei, Gong, Hui, Yilamujiang, Subinuer, Li, Li. 2022. Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population. In BMC pulmonary medicine, 22, 178. doi:10.1186/s12890-022-01975-3. https://pubmed.ncbi.nlm.nih.gov/35513865/
5. Han, Tao, Zheng, Hao, Zhang, Jin, Xiang, Daimin, Wang, Ruoyu. 2022. Downregulation of MUC15 by miR-183-5p.1 promotes liver tumor-initiating cells properties and tumorigenesis via regulating c-MET/PI3K/AKT/SOX2 axis. In Cell death & disease, 13, 200. doi:10.1038/s41419-022-04652-9. https://pubmed.ncbi.nlm.nih.gov/35236826/
6. Yue, Yangyang, Hui, Ke, Wu, Shiqi, Wu, Kaijie, Fan, Jinhai. 2020. MUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma. In Cell death & disease, 11, 336. doi:10.1038/s41419-020-2518-9. https://pubmed.ncbi.nlm.nih.gov/32382053/
智鼠故事 
